WEKO3
アイテム
{"_buckets": {"deposit": "0c1b566e-585d-49e6-8b02-c75df582a92e"}, "_deposit": {"created_by": 2, "id": "16774", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "16774"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00016774", "sets": ["30"]}, "author_link": ["64807", "64814", "64815", "64808", "64811", "64812", "64809", "64806", "64810", "64813"], "item_2_alternative_title_19": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Secondary endocrine therapy with oral estrogen for relapsed prostate cancer"}]}, "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2009-10", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "10", "bibliographicPageEnd": "598", "bibliographicPageStart": "595", "bibliographicVolumeNumber": "55", "bibliographic_titles": [{"bibliographic_title": "泌尿器科紀要"}, {"bibliographic_title": "Acta Urologica Japonica", "bibliographic_titleLang": "en"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "We report clinical outcomes of secondary endocrine therapy with oral estrogen for relapsed prostate cancer. A total of 18 patients were treated with oral estrogen as a secondary endocrine therapy for relapsed prostate cancer between February 2002 and December 2007. One mg/day of ethinylestradiol was administered orally and the dose was increased to 3 mg/day if necessary. A decrease of serum prostate specific antigenn (PSA) level was seen in all of the 15 patients who were able to take ethinylestradiol without severe side effects. The PSA level was decreased more than 50% in 11 out of 15 (73.3%) patients. Median re-relapse-free survival was 15 (3-32) months. This effectiveness was as good as intravenous high-dose diethylstilbestrol diphosphate (DES-DP) treatment which was used as a secondary endocrine therapy for relapsed prostate cancer at our institute previously. Oral administration of ethinylestradiol is effective and outpatients can be treated at a low cost, so it should be considered as one of the treatment options for relapsed prostate cancer after initial endocrine therapy.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "泌尿器科紀要, 55(10), pp.595-598; 2009", "subitem_description_type": "Other"}]}, "item_2_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "64811", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Onita, Toru"}]}, {"nameIdentifiers": [{"nameIdentifier": "64812", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Igawa, Tsukasa"}]}, {"nameIdentifiers": [{"nameIdentifier": "64813", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Hisamatsu, Hiroshi"}]}, {"nameIdentifiers": [{"nameIdentifier": "64814", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Sakai, Hideki"}]}, {"nameIdentifiers": [{"nameIdentifier": "64815", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Kanetake, Hiroshi"}]}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "泌尿器科紀要刊行会"}]}, "item_2_source_id_10": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00208315", "subitem_source_identifier_type": "NCID"}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00181994", "subitem_source_identifier_type": "ISSN"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "大仁田, 亨"}], "nameIdentifiers": [{"nameIdentifier": "64806", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "井川, 掌"}], "nameIdentifiers": [{"nameIdentifier": "64807", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "久松, 浩"}], "nameIdentifiers": [{"nameIdentifier": "64808", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "酒井, 英樹"}], "nameIdentifiers": [{"nameIdentifier": "64809", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "金武, 洋"}], "nameIdentifiers": [{"nameIdentifier": "64810", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-23"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "AUJ55_595.pdf", "filesize": [{"value": "2.9 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 2900000.0, "url": {"label": "AUJ55_595.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/16774/files/AUJ55_595.pdf"}, "version_id": "2f943658-a220-446c-b34e-49f915afb90a"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Oral estrogen", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Prostate cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Relapse", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "再燃前立腺癌に対する経口エストロゲンによる二次内分泌療法の治療成績", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "再燃前立腺癌に対する経口エストロゲンによる二次内分泌療法の治療成績"}]}, "item_type_id": "2", "owner": "2", "path": ["30"], "permalink_uri": "http://hdl.handle.net/10069/22659", "pubdate": {"attribute_name": "公開日", "attribute_value": "2009-12-24"}, "publish_date": "2009-12-24", "publish_status": "0", "recid": "16774", "relation": {}, "relation_version_is_last": true, "title": ["再燃前立腺癌に対する経口エストロゲンによる二次内分泌療法の治療成績"], "weko_shared_id": -1}
再燃前立腺癌に対する経口エストロゲンによる二次内分泌療法の治療成績
http://hdl.handle.net/10069/22659
http://hdl.handle.net/10069/2265988a60405-c1c6-42c3-9704-eec3cb68ecaa
名前 / ファイル | ライセンス | アクション |
---|---|---|
AUJ55_595.pdf (2.9 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2009-12-24 | |||||
タイトル | ||||||
タイトル | 再燃前立腺癌に対する経口エストロゲンによる二次内分泌療法の治療成績 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Oral estrogen | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Prostate cancer | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Relapse | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
大仁田, 亨
× 大仁田, 亨× 井川, 掌× 久松, 浩× 酒井, 英樹× 金武, 洋 |
|||||
著者別名 | ||||||
姓名 | Onita, Toru | |||||
著者別名 | ||||||
姓名 | Igawa, Tsukasa | |||||
著者別名 | ||||||
姓名 | Hisamatsu, Hiroshi | |||||
著者別名 | ||||||
姓名 | Sakai, Hideki | |||||
著者別名 | ||||||
姓名 | Kanetake, Hiroshi | |||||
その他のタイトル | ||||||
その他のタイトル | Secondary endocrine therapy with oral estrogen for relapsed prostate cancer | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | We report clinical outcomes of secondary endocrine therapy with oral estrogen for relapsed prostate cancer. A total of 18 patients were treated with oral estrogen as a secondary endocrine therapy for relapsed prostate cancer between February 2002 and December 2007. One mg/day of ethinylestradiol was administered orally and the dose was increased to 3 mg/day if necessary. A decrease of serum prostate specific antigenn (PSA) level was seen in all of the 15 patients who were able to take ethinylestradiol without severe side effects. The PSA level was decreased more than 50% in 11 out of 15 (73.3%) patients. Median re-relapse-free survival was 15 (3-32) months. This effectiveness was as good as intravenous high-dose diethylstilbestrol diphosphate (DES-DP) treatment which was used as a secondary endocrine therapy for relapsed prostate cancer at our institute previously. Oral administration of ethinylestradiol is effective and outpatients can be treated at a low cost, so it should be considered as one of the treatment options for relapsed prostate cancer after initial endocrine therapy. | |||||
書誌情報 |
泌尿器科紀要 en : Acta Urologica Japonica 巻 55, 号 10, p. 595-598, 発行日 2009-10 |
|||||
出版者 | ||||||
出版者 | 泌尿器科紀要刊行会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00181994 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00208315 | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | 泌尿器科紀要, 55(10), pp.595-598; 2009 |